Abstract
To determine the effect of interferon on the production of antibodies against hepatitis B virus, recombinantα-interferon was added only to the fifth vaccine injection in a non-responder group and to all three initial vaccine injections in a low-responder group. In the non-responder group, 27 % of the hemodialysis patients, 7 % of the renal transplant patients, and both medical staff members tested developed low serum concentrations of anti-HBs (< 25 mU/ml). Whereas in the low-responder group 60 % of the hemodialysis patients developed the same amount of antibodies as a placebo group of comparable patients (⩾ 25 mU/ml), 78% of the renal transplant patients showed a 25 % higher antibody concentration than a placebo group (half < 25 mU/ml;half < 50 mU/ml). According to these preliminary findingsα-interferon may have an adjuvant effect on hepatitis B vaccination.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vignaux, F. et al.: Effect of virus-induced interferon on the antibody response of suckling and adult mice. European Journal of Immunology 1980, 10: 767–772.
De Maeyer, E.: Interferon and the immune system: a review. In: De Maeyer, E., Galasso, G., and Schellekens, H. (ed.): The biology of the interferon system. Elsevier/ North Holland, Amsterdam, 1981, p. 203–209.
Vodopija, I. et al.: Treatment of persons exposed to rabies virus with human diploid cell strain rabies vaccine and human leukocyte interferon. In: De Maeyer, E., Galasso, G., and Schellekens, H. (ed.): The biology of the interferon system. Elsevier/North Holland, Amsterdam, 1981, p. 371–374.
Stevens, C. E., Goodman, A. I., Szmuness, W., Weseley, S. A., Fotino, M.: Hepatitis B vaccine: immune responses in haemodialysis patients. The Lancet 1980, ii: 1211–1213.
Zachoval, R., Frösner, G., Deinhaidt, F.: Impfung gegen Hepatitis B. Ergebnisse einer Immunogenitätsstudie. Münchner medizinische Wochenschrift 1981, 123: 1506–1508.
Grob, P. J., Binswanger, U., Zaruba, K., Joller-Jemelka, H. I., Schmid, M., Häcki, W., Blumberg, A., Abplanalp, A., Herwig, W., Iselin, H., Descoeudres, C.: Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Research 1983, 3: 43–52.
Grob, P. J.: Hepatitis B vaccination of renal transplant and hemodialysis patients. Scandinavian Journal of Infectious Diseases, Supplement 38: 28–32.
Francis, D. P., Hadler, S. C., Thompson, S. E. et al.: The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control Multi-Center Efficacy Trial Among Homosexual Men. Annals of Internal Medicine 1982, 97: 362–366.
Grob, P. J.: The significance of hepatitis B infection in patients on hemodialysis or with renal transplants. In: Krugman, S., Sherlock, S. (ed.) Proceedings of the European Symposium on Hepatitis B. Merck Sharp & Dohme International, Rahway, N. J., p. 39–48.
Szmuness, W.: Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols. Journal of Medical Virology 1979, 4: 327–340.
Lauchart, W., Feuerhake, A., Meiners, G., Pichlmayr, R., Müller, R.: Low response to active hepatitis-B vaccination in kidney allograft recipients. Transplantation Proceedings 1983, XV: 1092–1093.
Revillard, J. P.: Immunologic alterations in chronic renal insufficiency. Advances in Nephrology 1979, 8: 365–382.
Goldblum, S. E., Reed, W. P.: Host defenses and immunologic alterations associated with chronic hemodialysis. Annals of Internal Medicine 1980, 93: 597–613.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grob, P.J., Joller-Jemelka, H.I., Binswanger, U. et al. Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations. Eur. J, Clin. Microbiol. 3, 195–198 (1984). https://doi.org/10.1007/BF02014877
Issue Date:
DOI: https://doi.org/10.1007/BF02014877